Icosagen Development Programme 2019-2021 (Q3070648): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
Programme de développement d’Icosagène 2019-2021 | |||
Revision as of 06:43, 26 November 2021
Project Q3070648 in Estonia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Icosagen Development Programme 2019-2021 |
Project Q3070648 in Estonia |
Statements
180,721.80 Euro
0 references
401,604.0 Euro
0 references
45.0 percent
0 references
1 October 2019
0 references
27 March 2021
0 references
Icosagen Cell Factory OÜ
0 references
58°22'0.84"N, 26°39'47.41"E
0 references
61713
0 references
Icosagen Cell Factory arenguprogrammi tulemusena arendatakse välja produtsentrakuliinide arendusteenud kui toode ning viiakse ettevõtte digitaliseerimine ning personali teadlikkus oluliselt kõrgemale tasemele, mis tagab parema konkurentsivõime diagnostiliste antikehade arendamise ja efektiivse antikehade tootmisteenuse pakkumise turul. (Estonian)
0 references
The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services. (English)
16 August 2021
0 references
Identifiers
2014-2020.4.04.19-1127
0 references